BIOMAT Database Logo BIOMAT Database Logo

Inhibitory effect of carcinostatic agents on antitumour activity of immune lymphoid cells. 1966

Y Hashimoto, and H Sudo, and M Ishidate

UI MeSH Term Description Entries
D008466 Mechlorethamine A biologic alkylating agent that exerts its cytotoxic effects by forming DNA ADDUCTS and DNA interstrand crosslinks, thereby inhibiting rapidly proliferating cells. The hydrochloride is an antineoplastic agent used to treat HODGKIN DISEASE and LYMPHOMA. Chlorethazine,Chlormethine,Mechlorethamine Oxide,Mustine,Nitrogen Mustard,Nitrogen Mustard N-Oxide,Bis(2-chloroethyl)methylamine,Caryolysine,Cloramin,Embichin,Mechlorethamine Hydrochloride,Mechlorethamine Hydrochloride N-Oxide,Mechlorethamine N-Oxide,Methylchlorethamine,Mitomen,Mustargen,NSC-10107,NSC-762,Nitrogranulogen,Nitromin,Hydrochloride N-Oxide, Mechlorethamine,Hydrochloride, Mechlorethamine,Mechlorethamine Hydrochloride N Oxide,Mechlorethamine N Oxide,N-Oxide, Mechlorethamine Hydrochloride,N-Oxide, Nitrogen Mustard,NSC 10107,NSC 762,NSC10107,NSC762,Nitrogen Mustard N Oxide
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D011691 Puromycin A cinnamamido ADENOSINE found in STREPTOMYCES alboniger. It inhibits protein synthesis by binding to RNA. It is an antineoplastic and antitrypanosomal agent and is used in research as an inhibitor of protein synthesis. CL-13900,P-638,Puromycin Dihydrochloride,Puromycin Hydrochloride,Stylomycin,CL 13900,CL13900,P 638,P638
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012517 Sarcoma, Yoshida An experimental sarcoma of rats. Reticulum Cell-Like Sarcoma, Yoshida,Reticulum Cell Like Sarcoma, Yoshida,Yoshida Sarcoma
D015122 Mercaptopurine An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. 6-Mercaptopurine,1,7-Dihydro-6H-purine-6-thione,6-Mercaptopurine Monohydrate,6-Thiohypoxanthine,6-Thiopurine,6H-Purine-6-thione, 1,7-dihydro-,BW 57-323H,Leupurin,Mecaptopurine Anhydrous,Mercaptopurina Wellcome,Puri-Nethol,Purimethol,Purinethol,6 Mercaptopurine,6 Mercaptopurine Monohydrate,6 Thiohypoxanthine,6 Thiopurine,BW 57 323H,BW 57323H
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Y Hashimoto, and H Sudo, and M Ishidate
Effect of carcinostatic agents on exfoliated cancer cells of the stomach.
January 1970, Acta cytologica,
Y Hashimoto, and H Sudo, and M Ishidate
Antitumour effect of lymphoid cells activated by interferon.
October 1970, Nature,
Y Hashimoto, and H Sudo, and M Ishidate
Production of metastases by treatment with carcinostatic agents. 3. Low concentration of carcinostatic agents on the cells.
November 1973, Nagoya journal of medical science,
Y Hashimoto, and H Sudo, and M Ishidate
The differential inhibitory effect of lymphotoxin and immune interferon on normal and malignant lymphoid cells.
January 1985, Lymphokine research,
Y Hashimoto, and H Sudo, and M Ishidate
[Effect of the combined treatment of radiation and carcinostatic agents on Yoshida-sarcoma cells].
November 1965, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
Y Hashimoto, and H Sudo, and M Ishidate
Effect of the combined treatment of radiation and carcinostatic agents on Yoshida sarcoma cells.
December 1966, The Bulletin of Tokyo Medical and Dental University,
Y Hashimoto, and H Sudo, and M Ishidate
Effect of various carcinostatic agents on acridine orange uptake by Ehrlich ascites carcinoma cells.
February 1966, Gan,
Y Hashimoto, and H Sudo, and M Ishidate
Effect of carcinostatic agents on carcinomatous metastasis in the spleen.
December 1969, Gan,
Y Hashimoto, and H Sudo, and M Ishidate
Production of metastases by treatment with carcinostatic agents. I. Effects of carcinostatic agents on the host.
November 1961, Cancer research,
Y Hashimoto, and H Sudo, and M Ishidate
Study on the sensitivity test of carcinostatic agents by acid phosphatase activity.
March 1972, Nagoya journal of medical science,
Copied contents to your clipboard!